ControlRad™ Secures $15 Million Series B Financing, Expands Board of Directors

Financing Round Led by Questa Capital to Fuel Commercialization of ControlRad Trace Mobile C-arm Radiation Reduction Technology

Medical Device Industry Veterans Ryan Drant and Tim Patrick Join Board

ATLANTA, October 2, 2019 – ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures (FGP), today announced it completed $15 million in financing and that medical device industry veterans Ryan Drant  and Tim Patrick have joined its board of directors. The Series B round, which was led by Questa Capital, will be used for fueling the commercial launch of the innovative ControlRad Trace system. 

Read the full article here: https://www.controlrad.com/our-news/87-controlrad-secures-15-million-series-b-financing-expands-board-of-directors